VAERS reports by lot

GSK DTaP/Tdap lot 97NL3: VAERS reports

25 VAERS reports list lot 97NL3 as a GSK DTaP/Tdap vaccine, received between 2019-04-29 and 2021-08-03. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
25
Reports
4%
Marked serious
0
With a death outcome
10
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Dermatological (non-injection-site)1528%
Injection-site / Local reaction1325%
Neurological815%
Musculoskeletal713%
General / Systemic (non-local)48%
Cardiac / Cardiovascular24%
Allergic / Anaphylactic24%
Respiratory12%
Gastrointestinal12%

Where reports came from

U.S. state of the reporter, where given (top 12).

California3
Texas2
Alabama2
Pennsylvania2
Iowa1
Rhode Island1
Arizona1
New York1
Ohio1
North Carolina1
Kansas1
Montana1

Reports by month received

2019-042
2019-0511
2019-062
2019-073
2019-081
2019-101
2019-121
2020-092
2021-061
2021-081

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.